ANTIBACTERIAL AND ANTICARCINOGENIC EVALUATION OF COMMERCIAL CALENDULA OFFICINALIS AND TARAXACUM OFFICINALE
HTML Full TextANTIBACTERIAL AND ANTICARCINOGENIC EVALUATION OF COMMERCIAL CALENDULA OFFICINALIS AND TARAXACUM OFFICINALE
Ayşegül Karapınar Arif 1, Halit Özger 1, Kerem Cansever 1, Mehtap Kara * 2, Fatıma Nur Yılmaz 3, Berna Özbek Çelik 3
Medicana Educationa Institution - MBA Schools 1, Istanbul, 34100, Turkey.
Istanbul University 2, Faculty of Pharmacy, Department of Pharmaceutical Toxicology, Istanbul, 34116, Turkey.
Istanbul University 3, Faculty of Pharmacy Department of Pharmaceutical Microbiology-Istanbul, 34116, Turkey.
ABSTRACT: Public interest on herbal drugs increase every passing day in both developed and developing countries. However, its regulations more strict in developed countries than in developing countries. Clarifying the effectiveness and adverse effects of this product is becoming more important. Calendula officinalis and Taraxacum officinale both commonly using in herbal-based therapies due to the speculated antibacterial and anti-cancer effects of them. Several effects of these plants have been associated with their ingredients, such as phytochemicals, flavonoids, essential oils, etc. In this study, we aimed to investigate antibacterial effects and potential anticancer effects of commercial Calendula officinalis and Taraxacum officinale products obtained from herbalist. Antibacterial effects of methanolic extracts of Calendula officinalis and Taraxacum officinale were evaluated via microbroth dilution technique using the Clinical Laboratory Standards Institute (CLSI) recommendations. Anti-cancer effects were evaluated with the MTT cytotoxicity test on the human neuroblastoma cell line (SH-SY5Y). Our results indicate that commercial products show lower antibacterial effects separately and with 1:1 combination that was reported in previous different studies. It has been observed that both methanolic plant extracts were shown 100% viability in desired concentrations.
Keywords: |
Calendula officinalis, Taraxacum officinale
INTRODUCTION: Global usage of herbal products that include nutraceuticals and herbal medicines increases rapidly for the purpose of different cure types of diseases. Obtaining these products is very easy in developing countries. Most people in developing countries believed that herbal products as effective as a medical cure.
However, in developed countries, herbal products under strict control. Even though, these strict control protocols in developed countries, people embraced these types of remedies commonly. Due to several recent herbal drugs come into the market with increasing rate, efficacity, safety, and toxicity, studies gain importance every passing day.
Most herbal products come into the market without enough safety evaluation, and people use this product by themselves without expert prescriptions. Misuse of herbal products causes a wide range of adverse effect as allergy, liver, and other target organ toxicity, even death 1-5.
Callendula officinalis, Fig. 1A includes different types of phytochemicals as carotenoids, terpenoids, flavonoids, quinones, etc. that are used in herbal medicine for the cure. It has been speculated that C. officinalis exert anti-inflammatory, anti-bacterial and anti-fungal, antioxidant, hypoglycemic and gastroprotective, antidiabetic, anti-HIV, and anti-cancerous effects 7-15. C. officinalis use for the treatment of abrasions, burns, ulcers, skin inflammations, eczema, and wounds due to its anti-bacterial and anti-fungal effects. Different parts of the plant exert different effectiveness. Flower extracts Show higher antibacterial activity, however, reproductive parts of plants have lesser antibacterial activity. It has been reported that especially methanolic extract of the flower include great antibacterial activity against gram-negative and gram-positive bacteria 7. C. officinalis have antifungal effects on different candida species 6. Taraxacum officinale Fig. 1B, generally used in salads and vegetable foods. T. officinale include sesquiterpenes, lactones, glycoisdes, free sterols (taraxasterol and taraxerol), polysaccharides, pectin, resin and mucilage and various flavonoids. T. officinale generally used for liver and kidney problems, edema, skin problems, heartburn, and gastrointestinal problems. It has been speculated that T. officinale have Hypoglycemic effects, antyoxidant effect, diuretic, antibacterial and anti-inflammatory effects 3. In this study, we aimed to investigate antibacterial and cytotoxic effects of commercial Calendula officinalis, Taraxacum officinale products obtained from an herbalist.
MATERIALS AND METHODS:
Ethanolic Plant Extraction: 30 g Calendula officinalis and Taraxacum officinale commercial plants were weighed. 300 ml ethanol was added on separately added on plants and incubated for 24 h on a shaker. Ethanol was vaporized by distillation equipment. Dried extracts were stored at +4 ºC.
Cytotoxicity Evaluation-MTT Test: The MTT assay was performed to cytotoxic effects of the tested Calendula officinalis and Taraxacum officinale concentrations for each plant; 100 µg/ml, 50 µg/ml 25 µg/ml 12,5 µg/ml and solvent control as DMSO (1% finally). Human neuroblastoma (SH-SY5Y) cells were seeded into 96-well plates (1×104 cells/ 100 µl of medium/well) and incubated overnight. After the treatment of Calendula officinalis and Taraxacum officinale for 24 h, the MTT solution was added into each well, and the cells were further incubated for 3 h at 37 °C in the dark. After incubation, the medium was discarded, and 100 µl of DMSO was added to each well for dissolve formazan crystals. Optical density was measured at 570 nm by using a microplate reader (Biotek, Epoch, Vermont, USA).
Antibacterial Assay: Antibacterial activity of Calendula officinalis and Taraxacum officinale evaluated against Staphylococcus aureus ATCC 6538, Staphylococcus epidermidis ATCC 12228, Escherichia coli ATCC 25922, Klebsiella pneumoniae ATCC 4352, Pseudomonasa eruginosa ATCC 27853, Enterococcusfa ecalis ATCC 29212 ve Candida albicans ATCC 10231 by the micro broth dilution technique using the Clinical Laboratory Standards Institute (CLSI) recommendations. The MIC (minimum inhibitory concentration) values were determined by comparison with standard agents.
RESULTS:
Cytotoxicity Assay: According to MTT test results, Calendula officinalis and Taraxacum officinale extract administration exerts 100% viability on SH-SY5Y cell lines Table 1.
Antibacterial Assay Results: According to antibacterial assay results, it has been observed that ethanolic extracts of commercial Calendula officinalis and Taraxacum officinale products exerted low antibacterial activity, additionally their 1:1 combination showed very low antibacterial activity Table 2.
TABLE 1: VIABILITY (%) RESULTS OF CALENDULA OFFICINALIS AND TARAXACUM OFFICINALE BY MTT TEST
Calendula officinalis (µg/ml) | Viability (%) | Taraxacum official (µg/ml) | Viability (%) |
12,5 | 100 | 12,5 | 100 |
25 | 100 | 25 | 100 |
50 | 100 | 50 | 100 |
100 | 100 | 100 | 100 |
TABLE 2: ANTIBACTERIAL ACTIVITY RESULTS
Taraxacum officinale Starting Concentration:2000 μg/ml) | Calendula officinalis Starting Concentration: 2000 μg/ml) | 1:1 Combination Starting Concentration: 2000 μg/ml) | Reference (MIC) | |
(Pseudomonas aeruginosa) ATCC 27853 | 62,5 | 500 | 250 | Ceftazidime 2, 4 |
(Klebsiella pneumoniae) ATCC 4352 | 250 | 500 | 500 | Cefuroxime-Na 4, 9 |
(Escherichia coli) ATCC 25922 | 125 | 500 | 500 | Cefuroxime-Na 4,9 |
(Enterococcus faecalis) ATCC 29212 | 15,6 | 250 | 125 | Cefuroxime-Na 2, 4 |
(Staphylococcus epidermidis) ATCC 12228 | 125 | 500 | 500 | Cefuroxime-Na 9, 8 |
(Staphylococcus aureus) ATCC 29213 | 62,5 | 62,5 | 125 | Cefuroxime-Na 1, 2 |
(Candida albicans) ATCC 10231 | 125 | 500 | 500 | Clotrimazole 4, 9 |
MIC: minimun inhibitory concentration |
DISCUSSION: Several scientific studies on different therapeutic effects of several types of herbal drugs were published in scientific databases. Additionally, several speculative information’s publishing on media for different herbal drugs. People could try different plants that were obtained from herbalists or they could harvest to cure themselves. In case, it is very important to clarify the adverse effects of herbal drugs to deliver accurate information. It has been reported that different calendula species have antibacterial effects on different microbes 11. In our study commercial products, methanolic extract was shown lower antibacterial activity. Taraxacum officinale’ santibacterial effects were shown in different studies 8-16. In this study, Taraxacum officinale’ methanolic extract was shown lower antibacterial activity, additionally 1:1 combination of these two plants also exerts lower antibacterial activity. Several different studies are focusing on anticancer effects of Calendula officinalis and Taraxacum officinale plant extracts 9, 10. However, in our study, both of Calendula officinalis and Taraxacum officinale’s 100 µg/ml, 50 µg/ml 25 µg/ml 12, 5 µg/ml methanolic extracts concen-trations administration were shown 100% viability.
CONCLUSION: In conclusion, commercial Calendula officinalis and Taraxacum officinale products showed lower antibacterial effects separately and were not shown anti-cancer effects on the human neuroblastoma cell line. Further, in-vivo and in-vitro studies needed to clarify antibacterial and anti-cancer effects of these plants with different extraction methods. It is very important to inform the public correctly about herbal product collection, extraction methods, and therapeutic drug forms for the therapy.
ACKNOWLEDGEMENT: This study supported by Medicana Educational Institution - MBA Schools.
CONFLICTS OF INTEREST: The authors declare no conflict of interest.
REFERENCES:
- Bandaranayake WM: Quality control, screening, toxicity, and regulation of herbal drugs,’’ in Modern Phytomedicine. Turning Medicinal Plants into Drugs eds Ahmad I., Aqil F., Owais M., editors. (Weinheim:Wiley-VCH GmbH & Co. KGaA;) 2006; 25-57.
- Behbahani M: Evaluation of in-vitro anticancer activity of Ocimum basilicum, Alhagi maurorum, Calendula officinalis and their parasite Cuscuta campestris. PLoS One 2014; 309(12): 116049.
- Bensky D, Clavey S and Stöger E: Cuscuta campestris Gamble a: 2004. Chinese Herbal Medicine Materia Medica. Ed 3rd Seattle WA Eastland Press Clinical and Laboratory Standards Institute (CLSI) Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically: Approved Standard M7-A10. Wayne, Pennsylvania 2015.
- Efstratiou E, Hussain AI, Nigam PS, Moore JE, Ayub MA and Rao JR: Antimicrobial activity of Calendula officinalis petal extracts against fungi, as well as Gram-negative and Gram-positive clinical pathogens. Comple-ment Ther Clin Pract 2012; 18(3): 173-6.
- Ekor M: The growing use of herbal medicines: issues relating to adverse reactions and challenges in monitoring safety. Front Pharmacol 2014; 104: 177.
- Iauk L, Lo-Bue AM, Milazzo I, Rapisarda A and Blandino G: Antibacterial activity of medicinal plant extracts against periodontopathic bacteria. Phytot Res 2003; 17: 599- 604
- Jan N and John R: Calendula officinalis an important medicinal plant with potential biological properties. Proceedings of the Indian National Science Academy 2017; 83(4): 769-87.
- Lin L, Zhu Y, Li C, Liu L, Surendhiran D and Cui H: Antibacterial activity of PEO nanofibers incorporating polysaccharide from dandelion and its derivative. Carbohydr Polym 2018; (15)198: 225-32.
- Nassan MA, Soliman MM, Ismail SA and El-Shazly S: Effect of Taraxacum officinale extract on PI3K/Akt pathway in DMBA-induced breast cancer in albino rats. Biosci Rep 2018; 21; 38.
- Nguyen C, Mehaidli A, Baskaran K, Grewal S, Pupulin A, Ruvinov I, Scaria B, Parashar K, Vegh C and Pandey S: Dandelion root and lemongrass extracts induce apoptosis, enhance chemotherapeutic efficacy, and reduce tumour xenograft growth in-vivo in prostate cancer. Evid Based Complement Alternat Med 2019; 019(17): 2951428.
- Pedram Rad Z, Mokhtari J and Abbasi M: Calendula officinalis extract/PCL/Zein/Gum arabicnanofibrous bio-composite scaffolds via suspension, two-nozzle and multilayer electrospinning for skin tissue engineering. Int J Biol Macromol 2019; 135(15): 530-43.
- Rasool S and Sharma B: Taraxacum officinale: a high value less known medicinal plant. Ann Plant Sci 2014; 3: 908-15.
- Saratale RG, Benelli G, Kumar G, Kim DS and Saratale GD: Bio-fabrication of silver nanoparticles using the leaf extract of an ancient herbal medicine, dandelion (Taraxacum officinale), evaluation of their antioxidant, anticancer potential and antimicrobial activity against phytopathogens. Environ Sci Pollut Res Int 2018; 25(11): 10392-406.
- Sohail M, Iqbal Z, Afzal M, Afzal A, Ur Rahman I and Shad S: In-vitro antibacterial study of Taraxacumofficinale leaves extracts against different bacterial pathogenic strains. Journal of Pharmacognosy and Phytochemistry 2014; 3(2): 15-17.
- Tonks AJ, Dudley E, Porter NG, Parton J, Brazier J, Simth EL and Tonks A: A 5.8-kDa component of manuka honey stimulates immune cells via J Leukoc Biol 2007; 82: 1147-55.
- Wang HB: Cellulase-assisted extraction and antibacterial activity of polysaccharides from the dandelion Taraxacum officinale. Carbohydr Polym 2014; 15(103): 140-2.
How to cite this article:
Arif AK, Özger H, Cansever K, Kara M Fatıma NY and Çelik BO: Antibacterial: Antibacterial and anticarcinogenic evaluation of commercial Calendula officinal is and Taraxacum officinale. Int J Pharmacognosy 2020; 7(11): 322-25. doi link: http://dx.doi.org/ 10.13040/IJPSR.0975-8232.IJP.7(11).322-25.
This Journal licensed under a Creative Commons Attribution-Non-commercial-Share Alike 3.0 Unported License.
Article Information
8
322-325
685
610
English
IJP
A. K. Arif, H. Özger, K. Cansever, M. Kara *, F. N. Yılmaz, B. Ö. Çelik
Department of Pharmaceutical Microbiology, Faculty of Pharmacy, Istanbul University, Beyazit-Istanbul, Turkey.
mehtap.kara@istanbul.edu.tr
29 May 2020
23 September 2020
28 September 2020
10.13040/IJPSR.0975-8232.IJP.7(11).322-25
01 November 2020